Procept BioRobotics [PRCT] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison

Procept BioRobotics
NASDAQ
Loading...

Bio-Rad Laboratories
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Procept BioRobotics wins in 4 metrics, Bio-Rad Laboratories wins in 14 metrics, with 0 ties. Bio-Rad Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Procept BioRobotics | Bio-Rad Laboratories | Better |
---|---|---|---|
P/E Ratio (TTM) | -27.50 | 23.81 | Procept BioRobotics |
Price-to-Book Ratio | 6.84 | 1.00 | Bio-Rad Laboratories |
Debt-to-Equity Ratio | 21.02 | 19.73 | Bio-Rad Laboratories |
PEG Ratio | -36.18 | 22.69 | Procept BioRobotics |
EV/EBITDA | -26.72 | 17.51 | Procept BioRobotics |
Profit Margin (TTM) | -36.20% | 12.50% | Bio-Rad Laboratories |
Operating Margin (TTM) | -39.67% | 12.19% | Bio-Rad Laboratories |
EBITDA Margin (TTM) | N/A | 12.19% | N/A |
Return on Equity | -27.62% | 4.59% | Bio-Rad Laboratories |
Return on Assets (TTM) | -13.36% | 1.59% | Bio-Rad Laboratories |
Free Cash Flow (TTM) | $-103.62M | $266.20M | Bio-Rad Laboratories |
Dividend Yield | 0.64% | N/A | N/A |
1-Year Return | -25.26% | -18.45% | Bio-Rad Laboratories |
Price-to-Sales Ratio (TTM) | 10.69 | 2.79 | Bio-Rad Laboratories |
Enterprise Value | $2.43B | $7.19B | Bio-Rad Laboratories |
EV/Revenue Ratio | 9.75 | 2.81 | Bio-Rad Laboratories |
Gross Profit Margin (TTM) | 63.85% | 52.99% | Procept BioRobotics |
Revenue per Share (TTM) | $5 | $92 | Bio-Rad Laboratories |
Earnings per Share (Diluted) | $-1.69 | $11.10 | Bio-Rad Laboratories |
Beta (Stock Volatility) | 1.04 | 0.91 | Bio-Rad Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Procept BioRobotics vs Bio-Rad Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Procept BioRobotics | -3.07% | -18.39% | -30.51% | -25.46% | -43.09% | -52.39% |
Bio-Rad Laboratories | -0.39% | 9.63% | 7.37% | 14.07% | -22.47% | -18.67% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Procept BioRobotics | -25.26% | 4.46% | 14.23% | 14.23% | 14.23% | 14.23% |
Bio-Rad Laboratories | -18.45% | -51.66% | -47.62% | 81.37% | 212.59% | 366.92% |
Performance & Financial Health Analysis: Procept BioRobotics vs Bio-Rad Laboratories
Metric | PRCT | BIO |
---|---|---|
Market Information | ||
Market Cap | $2.66B | $7.12B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 1,476,630 | 421,200 |
90 Day Avg. Volume | 1,040,502 | 317,847 |
Last Close | $38.38 | $264.21 |
52 Week Range | $37.12 - $103.81 | $211.43 - $387.99 |
% from 52W High | -63.03% | -31.90% |
All-Time High | $103.81 (Nov 11, 2024) | $832.70 (Aug 30, 2021) |
% from All-Time High | -63.03% | -68.27% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.55% | 0.02% |
Quarterly Earnings Growth | 0.55% | 0.02% |
Financial Health | ||
Profit Margin (TTM) | -0.36% | 0.13% |
Operating Margin (TTM) | -0.40% | 0.12% |
Return on Equity (TTM) | -0.28% | 0.05% |
Debt to Equity (MRQ) | 21.02 | 19.73 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $7.04 | $263.42 |
Cash per Share (MRQ) | $5.72 | $50.76 |
Operating Cash Flow (TTM) | $-83,907,000 | $534.20M |
Levered Free Cash Flow (TTM) | $-58,771,876 | $223.40M |
Dividends | ||
Last 12-Month Dividend Yield | 0.64% | N/A |
Last 12-Month Dividend | $0.38 | N/A |
Valuation & Enterprise Metrics Analysis: Procept BioRobotics vs Bio-Rad Laboratories
Metric | PRCT | BIO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -27.50 | 23.81 |
Forward P/E | -36.18 | 22.69 |
PEG Ratio | -36.18 | 22.69 |
Price to Sales (TTM) | 10.69 | 2.79 |
Price to Book (MRQ) | 6.84 | 1.00 |
Market Capitalization | ||
Market Capitalization | $2.66B | $7.12B |
Enterprise Value | $2.43B | $7.19B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 9.75 | 2.81 |
Enterprise to EBITDA | -26.72 | 17.51 |
Risk & Other Metrics | ||
Beta | 1.04 | 0.91 |
Book Value per Share (MRQ) | $7.04 | $263.42 |
Financial Statements Comparison: Procept BioRobotics vs Bio-Rad Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PRCT | BIO |
---|---|---|
Revenue/Sales | $69.16M | $585.40M |
Cost of Goods Sold | $25.00M | $279.40M |
Gross Profit | $44.16M | $306.00M |
Research & Development | $16.40M | $73.50M |
Operating Income (EBIT) | $-27.44M | $23.70M |
EBITDA | $-22.39M | $98.50M |
Pre-Tax Income | $-24.74M | $83.40M |
Income Tax | N/A | $19.40M |
Net Income (Profit) | $-24.74M | $64.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PRCT | BIO |
---|---|---|
Cash & Equivalents | $316.21M | $521.40M |
Total Current Assets | $465.79M | $3.04B |
Total Current Liabilities | $52.06M | $506.60M |
Long-Term Debt | $77.83M | $1.33B |
Total Shareholders Equity | $389.16M | $6.68B |
Retained Earnings | $-570.72M | $7.48B |
Property, Plant & Equipment | $21.26M | $681.70M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PRCT | BIO |
---|---|---|
Operating Cash Flow | $-11.65M | $156.00M |
Capital Expenditures | $-1.84M | $-34.40M |
Free Cash Flow | $-18.82M | $95.50M |
Debt Repayment | N/A | $-100,000 |
Common Stock Repurchase | N/A | $-101.90M |
Short Interest & Institutional Ownership Analysis
Metric | PRCT | BIO |
---|---|---|
Shares Short | 6.82M | 894,308 |
Short Ratio | 9.53 | 2.47 |
Short % of Float | 0.15% | 0.05% |
Average Daily Volume (10 Day) | 1,476,630 | 421,200 |
Average Daily Volume (90 Day) | 1,040,502 | 317,847 |
Shares Outstanding | 54.72M | 28.01M |
Float Shares | 53.21M | 18.51M |
% Held by Insiders | 0.04% | 0.16% |
% Held by Institutions | 0.94% | 0.93% |
Dividend Analysis & Yield Comparison: Procept BioRobotics vs Bio-Rad Laboratories
Metric | PRCT | BIO |
---|---|---|
Last 12-Month Dividend | $0.38 | N/A |
Last 12-Month Dividend Yield | 0.64% | N/A |
3-Year Avg Annual Dividend | $0.53 | N/A |
3-Year Avg Dividend Yield | 0.12% | N/A |
3-Year Total Dividends | $1.59 | N/A |
Ex-Dividend Date | Mar 31, 2025 | N/A |